Real-time in vivo molecular detection of primary tumors and metastases with ratiometric activatable cell-penetrating peptides. - Test2 - elhamkhani - TriplyDB

Real-time in vivo molecular detection of primary tumors and metastases with ratiometric activatable cell-penetrating peptides.

Real-time in vivo molecular detection of primary tumors and metastases with ratiometric activatable cell-penetrating peptides.

http://www.wikidata.org/entity/Q30551927

about

Inhibition of regulated cell death by cell-penetrating peptides Intraoperative molecular imaging can identify lung adenocarcinomas during pulmonary resection.Tumor Detection at 3 Tesla with an Activatable Cell Penetrating Peptide Dendrimer (ACPPD-Gd), a T1 Magnetic Resonance (MR) Molecular Imaging Agent Use of indocyanine green for detecting the sentinel lymph node in breast cancer patients: from preclinical evaluation to clinical validation Advances in fluorescent-image guided surgery Label-free Detection of Lymph Node Metastases with US-guided Functional Photoacoustic Imaging.The status of contemporary image-guided modalities in oncologic surgery Sentinel lymph node biopsy revisited: ultrasound-guided photoacoustic detection of micrometastases using molecularly targeted plasmonic nanosensors.Very long-term memories may be stored in the pattern of holes in the perineuronal net.Increased precision of orthotopic and metastatic breast cancer surgery guided by matrix metalloproteinase-activatable near-infrared fluorescence probes Tunable protease-activatable virus nanonodes Dual targeting of integrin αvβ3 and matrix metalloproteinase-2 for optical imaging of tumors and chemotherapeutic delivery.Intraoperative imaging-guided cancer surgery: from current fluorescence molecular imaging methods to future multi-modality imaging technology.Microscopic lymph node tumor burden quantified by macroscopic dual-tracer molecular imaging Differential impact of adenosine nucleotides released by osteocytes on breast cancer growth and bone metastasis.Ratiometric activatable cell-penetrating peptides label pancreatic cancer, enabling fluorescence-guided surgery, which reduces metastases and recurrence in orthotopic mouse models.Nodal lymph flow quantified with afferent vessel input function allows differentiation between normal and cancer-bearing nodes.Internalization of Near-Infrared Fluorescently Labeled Activatable Cell-Penetrating Peptide and of Proteins into Human Fibrosarcoma Cell Line HT-1080.Combined TP53 mutation/3p loss correlates with decreased radiosensitivity and increased matrix-metalloproteinase activity in head and neck carcinoma.Tumor radiosensitization by monomethyl auristatin E: mechanism of action and targeted delivery.Surgical molecular navigation with ratiometric activatable cell penetrating peptide for intraoperative identification and resection of small salivary gland cancers.A Bright Future for Precision Medicine: Advances in Fluorescent Chemical Probe Design and Their Clinical Application Assessment of laparoscopic stomach preserving surgery with sentinel basin dissection versus standard gastrectomy with lymphadenectomy in early gastric cancer-A multicenter randomized phase III clinical trial (SENORITA trial) protocol.FRET-trackable biodegradable HPMA copolymer-epirubicin conjugates for ovarian carcinoma therapy.Image-guided tumor surgery: will there be a role for fluorescent nanoparticles?Molecular targeting of papillary thyroid carcinoma with fluorescently labeled ratiometric activatable cell penetrating peptides in a transgenic murine model Osteocytic connexin hemichannels suppress breast cancer growth and bone metastasis.In vivo targeting of hydrogen peroxide by activatable cell-penetrating peptides.BMVC test, an improved fluorescence assay for detection of malignant pleural effusions A matter of collection and detection for intraoperative and noninvasive near-infrared fluorescence molecular imaging: to see or not to see?Detection and monitoring of localized matrix metalloproteinase upregulation in a murine model of asthma.Fluorescence imaging in surgery.Therapeutic potential of cell-penetrating peptides.Fluorescence-guided surgery with live molecular navigation--a new cutting edge Fluorescent techniques in spine surgery.Cell penetration: scope and limitations by the application of cell-penetrating peptides.Bioresponsive probes for molecular imaging: concepts and in vivo applications.Intraoperative Tumor Detection Using a Ratiometric Activatable Fluorescent Peptide: A First-in-Human Phase 1 Study.MMP-2/9-Specific Activatable Lifetime Imaging Agent.Review of fluorescence guided surgery systems: identification of key performance capabilities beyond indocyanine green imaging.

P2860

Q26751423-CE1876F3-85C5-4221-BCDB-B83B1031FAE2 Q27308955-7ADEAD69-4938-4BDB-991F-13282DCA2C4C Q27320124-A64F245C-C211-4333-9D1B-07886837E917 Q27336227-2CB7ABFB-261B-45BA-BBED-C841C8E5CD4C Q28072620-5832F747-5F59-447C-BCD0-83E2EBB0C29C Q30371267-E61D7334-722A-4A55-A122-00831344E076 Q30394594-E8E536A9-32B4-49B2-BEAB-C3856F4D93C0 Q30401749-32CE2EDB-B7D7-4A31-85DA-57C8E1C9FA1D Q30541839-4633B3B4-C142-45E7-A3EF-6E123363DD71 Q30665907-00A38494-FA07-4420-BB39-7C074895A71A Q33716080-E6451A74-B543-4F37-A115-A26F7AE9DE24 Q33732724-5CA52386-FF63-479F-AA03-7F5D58098D7C Q34195631-B4D56291-3EDC-4DC6-AA81-694DFE35DB0A Q34473944-C41F5C73-BC03-4332-BE57-10770B435364 Q35044543-77E459F3-2355-47E5-ACFB-6C2B1D0F39DD Q35335567-63B7800A-6363-496E-B44E-0D977189CF5D Q35445614-C1A4222A-A602-4B81-8116-61CEBBD81D0E Q35535268-A5478714-EC32-45DB-868A-5712AE127F1B Q35593159-C833BF39-0858-48EF-817B-742B5ED245ED Q35691410-74CE9E18-9052-44B4-B277-4276CB6AEE84 Q35756441-33129712-E26F-4016-85C6-C946531E0A30 Q35942615-15C73FE7-F258-4F06-9F34-89088F61EB65 Q36035480-98789DFD-6D74-43FF-9813-8974E7300A3D Q36244719-BA2F94CA-B521-43CA-87E4-A630B30476D9 Q36994932-68729DFF-E145-4C04-B403-5258ECDC42E8 Q37179943-5D8F3D80-F22D-4EFF-9833-AAC516A5B73C Q37309831-53197777-164D-4DD4-99F9-9DC06DE4378E Q37593509-B25FC7FB-8CB8-434A-B88B-C93A574690E3 Q37595275-6EE3F475-7F41-4AC5-A096-2B24DAD9F781 Q37704364-C184C49A-262A-42F5-815B-0D67078240AE Q37707616-2337D46C-D6D7-43FD-B298-E610740A661E Q38075552-235C8FF9-8D72-43FC-8135-DB7D4CD807A0 Q38104407-8F72998B-3E9A-45BD-883E-F715AE6F7F29 Q38127288-D23CF29D-0892-4BA7-B820-D85CB34525F1 Q38193581-3EBE401B-9B0F-4A7B-A741-CC4AE3A36F71 Q38238902-AA54A549-6188-47E9-8607-A310C18A3EEC Q38420827-2F7DE8FD-556E-4EEB-8D20-25F46603D99D Q38683050-0D1175D2-8985-4A82-AB88-5BA2C9FB30BD Q38873636-D8A40A16-CD4E-4D8A-AE1D-E1366D56D1B8 Q38929889-0C417865-F622-47A4-8690-1F633E01E034

P2860

Real-time in vivo molecular detection of primary tumors and metastases with ratiometric activatable cell-penetrating peptides.

http://www.wikidata.org/entity/Q30551927

description

2012 nî lūn-bûn

@nan

2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Real-time in vivo molecular de ...... ble cell-penetrating peptides.

@ast

Real-time in vivo molecular de ...... ble cell-penetrating peptides.

@en

type

label

Real-time in vivo molecular de ...... ble cell-penetrating peptides.

@ast

Real-time in vivo molecular de ...... ble cell-penetrating peptides.

@en

prefLabel

Real-time in vivo molecular de ...... ble cell-penetrating peptides.

@ast

Real-time in vivo molecular de ...... ble cell-penetrating peptides.

@en

P1433

Q30551927-24560D4E-C1E6-4F8C-9624-0249D0D22124

P1476

Q30551927-159CBF73-D65C-4610-946E-C242A7EE130E

P2093

Q30551927-1A71A55E-4EF9-4F74-B6DF-757049B2E378

Q30551927-32837EA9-C60A-41E7-8524-855AAD16CE26

Q30551927-43CF0A0A-920B-439A-B9D4-4F84BB797764

Q30551927-44C8B0BC-7C7D-4863-AF6E-E796A9319829

Q30551927-4D0D0C80-5E52-40AA-A7E1-ECA3CAC0F6C1

Q30551927-8A05189C-0CC4-43CB-BDFD-5DF16A1BC74C

Q30551927-A9E8E031-554F-497F-B6F2-366967180F8B

Q30551927-E2EBDA04-3B83-4EF9-8EC7-08E55371AA56

P2860

Q30551927-09DE7DB5-D0D6-42D8-9C37-0242C3CC798C

Q30551927-0FE45952-A3FD-41FE-B5A1-D161AE1A8DE1

Q30551927-14DC0138-87CD-48E3-9EA3-FC4A6D296289

Q30551927-1AE5BACE-B938-44DC-93D0-56D1AAFD302F

Q30551927-28A919FE-F555-4070-9837-409920EF8669

Q30551927-2FF02429-56F3-4E81-A34A-7AB119D0F2E7

Q30551927-3B57D38D-E1E1-49D2-9F3A-A9E66F640CBC

Q30551927-57B2E1C3-9870-461C-9FFB-6C1CDC5AF0C3

Q30551927-5DCFDD8E-D5F0-43A4-9EFD-1438E0C5E51A

Q30551927-6F105087-5A91-4C76-9737-832521DEAD4C

P304

Q30551927-C00B81AC-EEFC-4E19-B2BF-74DC8CC464F4

P31

Q30551927-916BA6C5-7546-406E-B31B-C247A7FD135D

P356

Q30551927-42B64D5E-C91A-47BA-928C-3006BFE3897E

P407

Q30551927-A89EAE41-3926-4C62-830C-2C510B86A714

P433

Q30551927-E7B6A3F4-1C44-40BD-BB34-6781C1A9D587

P478

Q30551927-94E396E0-75A2-436F-B802-842DB5139706

P577

Q30551927-26ACC1DD-2E2F-4268-B524-F0E47D584606

P5875

Q30551927-B2EA0BAC-6FAE-4519-904B-D817CB2A76AC

P698

Q30551927-A2BE9A80-CD3B-4783-9B05-72FBAB000016

P932

Q30551927-5FAC92FB-81D6-46DE-8429-BEAAB548EEA5

P356

0008-5472.CAN-12-2969

P1433

Cancer Research

P1476

Real-time in vivo molecular de ...... ble cell-penetrating peptides.

@en

P2093

Csilla N Felsen

http://www.w3.org/2001/XMLSchema#string

Elamprakash N Savariar

http://www.w3.org/2001/XMLSchema#string

Lesley G Ellies

http://www.w3.org/2001/XMLSchema#string

Nadia Nashi

http://www.w3.org/2001/XMLSchema#string

Paul Steinbach

http://www.w3.org/2001/XMLSchema#string

Quyen T Nguyen

http://www.w3.org/2001/XMLSchema#string

Roger Y Tsien

http://www.w3.org/2001/XMLSchema#string

Tao Jiang

http://www.w3.org/2001/XMLSchema#string

P2860

Spectral imaging in preclinical research and clinical pathology

Real-time video imaging of protease expression in vivo

Tumor imaging by means of proteolytic activation of cell-penetrating peptides

Parallel in vivo and in vitro selection using phage display identifies protease-dependent tumor-targeting peptides.

Surgery with molecular fluorescence imaging using activatable cell-penetrating peptides decreases residual cancer and improves survival.

Activatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteases.

In vivo molecular target assessment of matrix metalloproteinase inhibition.

Design, synthesis, and imaging of an activatable photoacoustic probe.

Development of an orthotopic model of invasive pancreatic cancer in an immunocompetent murine host.

Optimization of near-infrared fluorescent sentinel lymph node mapping for vulvar cancer.

P304

855-864

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-12-2969

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

73

http://www.w3.org/2001/XMLSchema#string

P577

2012-11-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233789222

http://www.w3.org/2001/XMLSchema#string

P698

23188503

http://www.w3.org/2001/XMLSchema#string

P932

3799878

http://www.w3.org/2001/XMLSchema#string